The public record for this company is narrow and specific. A single 510(k) record, K254246, links the applicant name to the LT Antibacterial Foam with Silver Dressing, received December 29, 2025, and decided September 10, 2026 as substantially equivalent. The FDA letter for that submission lists product code FRO and an unclassified regulatory class, while the database record lists NAD and Class 1. Company-published pages describe silver ion foam dressings in plain and self-adhesive forms. [1][4][6]
The K254246 submission and its decision
K254246 was received on December 29, 2025, and decided on September 10, 2026 with decision code SESE, meaning substantially equivalent. The submission is a Traditional 510(k), was not reviewed by a third party, and is flagged as a combination product. The review panel is General and Plastic Surgery. The FDA database record names the device as LT Antibacterial Foam with Silver Dressing and lists product code NAD with regulation number 878.4020 and device class 1. [1][2]
The clearance letter dated September 10, 2026 is addressed to Claudia Zsang, Director of Regulatory Affairs, at Shuangshan Rd. 277, Fuxi St., Deqing, Zhejiang 313200, China. That letter identifies the device as LT Antibacterial Foam with Silver Dressing, gives product code FRO, and describes the regulatory class as unclassified. It records the submission as dated August 8, 2026 and received August 10, 2026. The database entry and the letter therefore differ on product code and class, and both are reported here as published. [4]
Documented product technology
Company-published product pages describe a silver ion foam antibacterial dressing as an antibacterial absorption covering dressing built on soft, hydrophilic polyurethane foam with an elastic, semi-breathable film backing that releases silver ions when absorbing exudate. A self-adhesive version is described as combining polyurethane foam, film and sodium carboxymethyl cellulose in a three-dimensional absorbent structure, with the adhesive format intended to reduce the need for separate fixation dressings. These are the manufacturer’s own product descriptions, not independently verified test results. [6][8]
The company website presents Zhejiang Longterm Medical Technology Co., Ltd. as a China-based manufacturer and supplier of wound dressings and medical occlusive dressings, and its product pages describe it as an OEM supplier of silver ion foam dressings. The site states that its information is intended for use only in countries and jurisdictions outside the People’s Republic of China. No customer names, sales figures or independent clinical results appear in the public information. [5][6]
Earlier silver dressing filing
An earlier FDA clearance letter, K192478 dated June 17, 2020, names the same company and the same regulatory affairs contact for the LT Antibacterial Alginate with Silver Dressing, also under product code FRO and an unclassified regulatory class. That letter lists predicate devices K172570 and K053590. It shows a prior silver-containing dressing submission from this applicant, separate from the 2026 foam dressing clearance. [9]
Registration and identity scope
An FDA establishment registration search for registration number 3009655869 returns one result, Zhejiang Longterm Medical Technology Co., LTD, listed under China. The company’s own site gives its address as No. 277, Shuangshan Road, Deqing County, Huzhou City, Zhejiang Province, China. The public information does not establish a parent company, brand ownership or corporate group structure, so none is asserted here. [3][6]

